(Q42694639)

English

Effect of augmentation with olanzapine in outpatients with depression in partial remission with melancholic features: consecutive case series

scientific article published on March 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Effect of augmentation with olanzapine in outpatients with depression in partial remission with melancholic features: consecutive case series (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

author name string

Koji Nozawa

1

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Atsushi Sekine

2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Satoshi Hozumi

3

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Tetsuo Shimizu

4

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

publication date

1 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Psychiatry and Clinical Neurosciences

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

199-202

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02184.X

21 January 2018

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02184.X

21 January 2018

Augmentation with olanzapine in TCA-refractory depression with melancholic features: a consecutive case series

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02184.X

21 January 2018

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02184.X

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02184.X

21 January 2018

Extrapyramidal reactions in Asians

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02184.X

21 January 2018

Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02184.X

21 January 2018

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02184.X

21 January 2018

Identifiers

10.1111/J.1440-1819.2010.02184.X

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42694639&oldid=2086694036"